173 related articles for article (PubMed ID: 35524452)
21. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Lee GB; Lee JC; Moon MH
Anal Chim Acta; 2019 Jul; 1063():117-126. PubMed ID: 30967175
[TBL] [Abstract][Full Text] [Related]
22. Discrimination of urinary exosomes from microvesicles by lipidomics using thin layer liquid chromatography (TLC) coupled with MALDI-TOF mass spectrometry.
Singhto N; Vinaiphat A; Thongboonkerd V
Sci Rep; 2019 Sep; 9(1):13834. PubMed ID: 31554842
[TBL] [Abstract][Full Text] [Related]
23. Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture.
Eylem CC; Yilmaz M; Derkus B; Nemutlu E; Camci CB; Yilmaz E; Turkoglu MA; Aytac B; Ozyurt N; Emregul E
Cancer Lett; 2020 Jan; 469():186-194. PubMed ID: 31669517
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
25. Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of pro-coagulant platelet extracellular vesicles.
Tafelmeier M; Fischer A; Orsó E; Konovalova T; Böttcher A; Liebisch G; Matysik S; Schmitz G
J Steroid Biochem Mol Biol; 2017 May; 169():176-188. PubMed ID: 27163393
[TBL] [Abstract][Full Text] [Related]
26. Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis.
Wang X; Gu X; Song H; Song Q; Gao X; Lu Y; Chen H
Anal Chim Acta; 2015 Sep; 893():77-83. PubMed ID: 26398425
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
[TBL] [Abstract][Full Text] [Related]
28. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.
Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS
Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934
[TBL] [Abstract][Full Text] [Related]
29. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
[TBL] [Abstract][Full Text] [Related]
30. Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson's Disease.
Qiu J; Wei L; Su Y; Tang Y; Peng G; Wu Y; He Y; Liu H; Guo W; Wu Z; Xu P; Mo M
Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626522
[TBL] [Abstract][Full Text] [Related]
31. A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer.
Lin HM; Mahon KL; Weir JM; Mundra PA; Spielman C; Briscoe K; Gurney H; Mallesara G; Marx G; Stockler MR; PRIMe Consortium ; Parton RG; Hoy AJ; Daly RJ; Meikle PJ; Horvath LG
Int J Cancer; 2017 Nov; 141(10):2112-2120. PubMed ID: 28741687
[TBL] [Abstract][Full Text] [Related]
32. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
33. Lipidomic analysis of serum exosomes identifies a novel diagnostic marker for type 2 diabetes mellitus.
Zhang L; Lu T; Zhou B; Sun Y; Wang L; Qiao G; Yang T
Lab Med; 2024 May; ():. PubMed ID: 38809765
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive lipidome profiling of isogenic primary and metastatic colon adenocarcinoma cell lines.
Fhaner CJ; Liu S; Ji H; Simpson RJ; Reid GE
Anal Chem; 2012 Nov; 84(21):8917-26. PubMed ID: 23039336
[TBL] [Abstract][Full Text] [Related]
35. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients.
Yang J; Wang M; Yang D; Yan H; Wang Z; Yan D; Guo N
Front Endocrinol (Lausanne); 2022; 13():1065665. PubMed ID: 36743922
[TBL] [Abstract][Full Text] [Related]
36. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
37. Fatty Acid Unsaturation Degree of Plasma Exosomes in Colorectal Cancer Patients: A Promising Biomarker.
Bestard-Escalas J; Reigada R; Reyes J; de la Torre P; Liebisch G; Barceló-Coblijn G
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064646
[TBL] [Abstract][Full Text] [Related]
38. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.
Sanchez JI; Jiao J; Kwan SY; Veillon L; Warmoes MO; Tan L; Odewole M; Rich NE; Wei P; Lorenzi PL; Singal AG; Beretta L
Cancer Prev Res (Phila); 2021 Oct; 14(10):955-962. PubMed ID: 34253566
[TBL] [Abstract][Full Text] [Related]
39. Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes.
Lydic TA; Townsend S; Adda CG; Collins C; Mathivanan S; Reid GE
Methods; 2015 Oct; 87():83-95. PubMed ID: 25907253
[TBL] [Abstract][Full Text] [Related]
40. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Ji H; Greening DW; Barnes TW; Lim JW; Tauro BJ; Rai A; Xu R; Adda C; Mathivanan S; Zhao W; Xue Y; Xu T; Zhu HJ; Simpson RJ
Proteomics; 2013 May; 13(10-11):1672-86. PubMed ID: 23585443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
